AMED and Inserm Signed a Memorandum of Cooperation to Strengthen Collaboration

The Japan Agency for Medical Research and Development (AMED)　signed a Memorandum of Cooperation (MOC) with the French National Institute of Health and Medical Research (Inserm) on October 2, 2026 in Tokyo, to strengthen cooperation in medical research and development.

The signing ceremony took place at the Embassy of France in Japan on the occasion of the official opening of Inserm’s representative office in Asia. The MOC was signed by Dr. Hitoshi Nakagama, President of AMED and Professor Didier Samuel, CEO of Inserm. Under this MOC, AMED and Inserm will enhance collaboration in areas of mutual interest, including immunology, inflammation, infectious diseases, microbiology, and other fields of biomedical research.

In addition to AMED, Inserm also signed cooperation agreements with RIKEN, the Institute of Industrial Science, The University of Tokyo, and the National Institute for Environmental Studies (NIES).

Through this partnership, AMED and Inserm aim to further promote international scientific cooperation and accelerate the advancement of biomedical research for the benefit of global health.